Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Affiliation country
Publication year range
1.
AANA J ; 90(3): 181-187, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35604860

ABSTRACT

With the current opiate epidemic in the United States, there is renewed interest in evaluating non-opiate adjuvant medications as effective alternatives for the prevention and treatment of postoperative pain. A systematic review of randomized, controlled trials on Pub Med, Medline, and Embase was conducted looking on postoperative pain management from 2008 to 2018. Studies were included if they used a gabapentenoid with or without acetaminophen and evaluated supplemental opiate use. All adult (18 years or older) surgical populations were considered for inclusion, and fourteen clinical trials met inclusion criteria. Gabapentenoid dosing varied among studies. In nine of fourteen studies, there was a finding of superiority as compared to placebo in managing postoperative pain and decreasing supplemental opiate use. Pregabalin was used in twelve of the fourteen studies and gabapentin was used in two of the fourteen studies. Of the nine studies that found a benefit from using a gabapentoid, all included pregabalin. While the rate of adverse effects was low in all studies, it was found to increase as dosages increased. Results support that pregabalin has a role in decreasing postoperative pain intensity and supplemental opiate use; however, the optimal dose or dosing regimen is not yet well understood.


Subject(s)
Cyclohexanecarboxylic Acids , Opiate Alkaloids , Acetaminophen/therapeutic use , Adult , Analgesics/therapeutic use , Analgesics, Opioid/therapeutic use , Cyclohexanecarboxylic Acids/adverse effects , Humans , Opiate Alkaloids/therapeutic use , Pain, Postoperative/drug therapy , Pregabalin/therapeutic use , gamma-Aminobutyric Acid/therapeutic use
2.
J Robot Surg ; 16(4): 967-971, 2022 Aug.
Article in English | MEDLINE | ID: mdl-34741712

ABSTRACT

In the current opioid crisis, multimodal analgesic protocols should be considered to reduce or eliminate narcotic usage in the postoperative period. We assess the impact of bupivacaine liposome used along with a standard analgesia protocol following robotic inguinal hernia repair. A retrospective review of a prospectively maintained data including robotic inguinal hernia repairs (IHR) by two surgeons in the United States was performed. Within a multimodal analgesic protocol, local anesthetic was administered intraoperatively. One group received a mix of bupivacaine and bupivacaine liposome (BL), and one received standard bupivacaine (SB). Recovery room and home opiate doses were recorded. Primary outcomes included length of stay (LOS) and postoperative medication requirements. Statistical analysis was performed using Chi-square or Fisher's exact test and Mann-Whitney U test as appropriate. 122 robotic IHRs were included; 55 received BL and 67 received SB. Hospital LOS (hours) was reduced in the BL group (2.8 ± 1.1 vs 3.5 ± 1.2; p = 0.0003). There was no significant difference in recovery room parenteral MME requirements between the groups; however, BL group had less oral MME requirements (5.0 ± 6.5 MME vs. 8.1 ± 6.9 MME, p = 0.02). The BL group had a higher rate of zero opiate doses at home (44% vs 5%, p = 0.0005). Of those that did require opiates at home, there was a significant reduction in number of narcotic pills used by the BL compared to the SB group (median 1 vs 5, respectively; p < 0.0001). Intraoperative administration of BL as part of a pain management protocol may decrease length of hospital stay, and reduce or eliminate the need for narcotic analgesic use at home.


Subject(s)
Hernia, Inguinal , Opiate Alkaloids , Robotic Surgical Procedures , Analgesics , Analgesics, Opioid/therapeutic use , Anesthesia, Local , Anesthetics, Local , Bupivacaine , Hernia, Inguinal/surgery , Herniorrhaphy , Humans , Length of Stay , Liposomes/therapeutic use , Narcotics , Opiate Alkaloids/therapeutic use , Pain, Postoperative/drug therapy , Pain, Postoperative/prevention & control , Postoperative Period , Robotic Surgical Procedures/methods
3.
Schmerz ; 21(4): 339-44, 346, 2007 Aug.
Article in German | MEDLINE | ID: mdl-17593402

ABSTRACT

One cannot have an idea of this multifaceted theme without its medical and cultural-historical background. After a history of several thousand years as a remedy and consumer good, around 1800 this poppy drug was in the focus of public attention due to Brownianism, at first as an often self-prescribed unspecific remedy against physical and mental pain. Many representatives of the early Romanticism knew it from personal experience. However, it was the publication of Thomas de Quincey's Confessions of an English Opium-Eater (1821/1822) which made it a subject of international debate in accordance with the programmatic statements of writers of that epoque and corresponding to the antibourgeois attitude of these men. It became a motif of a counter-world experience and a subject and cause of lyric-subjective reflection as well as a possible premise of poetic creativity.


Subject(s)
Analgesics, Opioid/history , Medicine in Literature , Opiate Alkaloids/history , Opioid-Related Disorders/history , Opium/history , Pain/drug therapy , Pain/history , Analgesics, Opioid/therapeutic use , England , Germany , History, 19th Century , History, 20th Century , Humans , Opiate Alkaloids/therapeutic use , Opium/therapeutic use , United States
SELECTION OF CITATIONS
SEARCH DETAIL